Feasibility of personalized adiuvant chemotherapy of gastric cancer utilizing expression profiling, polymorphism and methylation of genes associated with metabolism and pharmacodynamics of cisplatin and fluorouracil

2011/01/B/NZ4/03692

Keywords

Descriptors

  • NZ2_2: Genomika, transkryptomika i epigenomika
  • NZ4_11: Biologia nowotworów
  • NZ5_7: Leczenie chorób człowieka

Panel

NZ4 – Biology of tissues, organs and organisms: morphology and functions of animal's and human's systems, organs and organisms, experimental medicine, basics of neurology

Host institution

Uniwersytet Jagielloński- Collegium Medicum, Wydział Lekarski

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr hab. Piotr Kołodziejczyk

Number of co-investigators in the project: 15

Call

OPUS 1 – announced on 2011-03-15

Amount awarded
557 500 PLN
Project start date
2011-12-16
Project end date
2014-12-15
Project duration
36 months (the same as in the proposal)
Project status
Project settled

Equipment purchased [PL]

  1. Termocykler 96 dołkowy do Real-Time PCR. Cost: 200 000 PLN

Information in the final report

Publication in academic press/journals (1)

  1. CD44+ cytokeratin-positive tumor cells in blood and bone marrow are associated with poor prognosis of patients with gastric cancer

    Authors:
    Antoni Szczepanik, Marek Sierzega, Grażyna Drabik, Anna Pituch-Noworolska, Piotr Kolodziejczyk, Marek Zembala
    Academic press:
    Gastric Cancer (year: 2018, volume: 21, pages: 46031), Publisher: Springer Nature
    Status:
    Published
    DOI:
    10.1007/s10120-018-0858-2 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski